In a Melbourne laboratory, researchers have cracked a problem that has eluded parasitologists for decades: how to reliably identify the invisible invaders living in human and animal gut systems. A breakthrough diagnostic test developed at the University of Melbourne and the University of New South Wales can now detect the complete diversity of parasitic roundworms—including rare species and those transmitted from animals to humans—from a single stool sample, using advanced genomic sequencing technology that is small enough to work in the field.
The challenge this test solves is both urgent and vast. Parasitic nematodes infect approximately 1.5 billion people globally, with children and women of childbearing age bearing a disproportionate burden, particularly in low-to-middle income nations where access to clean water, sanitation, and healthcare remains limited. These worms—which include hookworms, threadworms, and whipworms—cause some of the world's most common Neglected Tropical Diseases, stunting child growth and development while draining health systems with expensive mass drug administration programs.
The conventional methods doctors and veterinarians have relied on for decades are simply inadequate. Microscopy, the traditional approach, requires examining feces for worm eggs or larvae, but many species look identical under the microscope, making accurate diagnosis nearly impossible. More advanced molecular techniques like PCR can detect worm DNA but can only identify a handful of species at once and consistently miss rare, unusual, or entirely new species that flourish in disease-endemic regions. "Recent investigations into human-infecting worms have revealed that their diversity is higher than previously thought, meaning that a test able to correctly detect and identify these nematodes is urgently needed to correctly address the diseases they cause," said Dr. Vito Colella from the research team.
The new test, published in The Lancet Microbe, leaps past these limitations by identifying each parasite's unique genetic signature. The team leveraged advanced genomic sequencing to develop a method that captures the entire parasitic nematode community present in a sample—sometimes as many as 10 different species from a single animal's gut. Being able to detect all worm species simultaneously matters because different species affect host health in dramatically different ways, and the composition of the parasite community determines which treatments will actually work.
The stakes extend beyond human health. Animals suffer acutely from these parasites, experiencing weight loss, decreased fertility, and even death. In Australia's sheep industry alone, the Barber's pole worm causes more than $436 million in losses annually. Cats and dogs infected with parasitic worms become anemic, lose weight, and face life-threatening complications. Critically, some of these worms jump from animals to humans—they are zoonotic—making their accurate identification essential for breaking transmission chains between species.
What makes this test genuinely revolutionary is its portability. Unlike laboratory sequencing equipment typically confined to hospitals and research centers, this technology is small and portable enough to be deployed in field settings where Neglected Tropical Diseases are most prevalent. This means communities without sophisticated medical infrastructure can finally access the diagnostic precision that has only been available in wealthy nations.
The research team has validated their test against the most accurate gold standard methods currently available, confirming its sensitivity and specificity. By correctly identifying rare and zoonotic parasites that standard tests miss, this tool promises to transform how health systems understand parasite diversity, design targeted interventions, and ultimately control some of the world's most persistent infections.